公司概述
Horizon Technology Finance Corporation operates as a business development company primarily engaged in lending and investing in development-stage assets within the technology, life science, and healthcare sectors. The firm specializes in providing secured debt and venture lending investments to venture capital-backed companies, targeting early-stage growth opportunities in high-potential industries. It functions within the Financial Services sector, specifically under the Asset Management industry classification, which defines its role in managing capital allocation for specialized lending strategies. With a market capitalization of $217.51M and annual revenue of $96.02M, the company maintains a scale indicative of a mid-cap entity focused on niche markets rather than broad consumer exposure. Although the employee count is not publicly disclosed, the revenue and market cap figures suggest a lean operational structure typical of business development companies that leverage external capital to fund their lending portfolio. This valuation places the company in a specific tier of financial service providers where asset quality and investment yield are more critical drivers than traditional volume-based revenue models.
财务健康
The company reported a trailing twelve-month revenue of $96.02M against a net income of -$2,661,000, while EBITDA figures are not available for calculation. The significant negative gap between revenue and net income reveals a cost structure where operating expenses and interest obligations substantially erode the bottom line, resulting in a profit margin of -2.8% despite a gross margin of 100.0%. This 100.0% gross margin indicates that the core lending or investment income is recorded as direct revenue without significant cost of goods sold, which is characteristic of financial intermediaries. However, the operating margin of 78.5% suggests that fixed operating costs are relatively low compared to revenue, yet the overall profitability remains negative due to interest expenses or realized losses. The firm generated free cash flow of $38.24M, which provides a crucial buffer for financial flexibility despite the accounting loss on the income statement. This positive cash flow allows the company to service its debt obligations and potentially fund new lending activities without immediate reliance on external equity issuance. In terms of liquidity and leverage, the company holds $105.52M in cash against total debt of $473.03M, resulting in a debt-to-equity ratio of 148.52, which indicates a highly leveraged balance sheet typical for business development companies. The current ratio of 1.56 suggests that the company possesses adequate short-term assets to cover its short-term liabilities, maintaining a conservative stance on immediate liquidity risks. Return on Equity stands at -0.8%, reflecting the negative impact of losses on shareholder equity, whereas Return on Assets is 6.0%, indicating that the underlying asset portfolio generates positive returns before financing costs are deducted.
估值评估
Horizon Technology Finance Corporation does not have a trailing P/E ratio available due to its negative earnings, but it trades with a forward P/E of 5.99. The absence of a trailing P/E and the presence of a low forward P/E implies that the market is pricing in an expectation of future earnings recovery or turnaround, though historical profitability remains absent. The price-to-book ratio is 0.65, indicating that the stock is trading at a significant discount to its book value, which often signals market skepticism regarding the quality of assets or the realization of future cash flows. Alternatively, this low ratio may reflect the high-risk nature of venture lending investments that are not fully captured on the balance sheet. The price-to-sales ratio stands at 2.27, and the EV/EBITDA is not available, suggesting that valuation is being driven primarily by revenue multiples rather than earnings multiples in the current market environment. Regarding price momentum, the stock has a 52-week high of $9.07 and a 52-week low of $3.98. Without a specific current price provided in the facts, the trading range indicates significant volatility over the past year, with a potential swing of over 50% between the high and low points. The stock exhibits a beta of 1.09, meaning its price volatility is slightly higher than the broader market, suggesting it reacts more sensitively to market downturns or sector-specific risks.
Growth & Income
Revenue growth year-over-year declined by 12.2%, while earnings growth is not available due to the company's current loss position. The contraction in revenue suggests a tightening lending pipeline or a shift in the investment cycle within the technology and healthcare sectors the company targets. The earnings trajectory is unclear but the negative net income contrasts with the positive free cash flow, highlighting the difference between accounting profits and actual cash generation. The company offers a dividend yield of 25.7%, which is exceptionally high for a financial services firm. However, the payout ratio stands at 224.6%, meaning the company is paying out far more in dividends than it generates in net income. This unsustainable payout ratio indicates that dividends are being funded by cash reserves or external financing rather than organic earnings, posing a potential risk if cash flows deteriorate. Given the negative net income and high payout ratio, the company is not reinvesting earnings into growth via dividends but rather distributing capital that may deplete its cash reserves over time. The overall growth and income profile is characterized by declining revenue, negative earnings, and a potentially unsustainable dividend policy that relies heavily on the company's substantial cash balance.